Four cases are presented in which subconjunctival administration of repository corticosteroids was associated with a rise in intraocular pressure. The pressure rise was maintained as long as steroid material was visible, and in two cases treatment was required to lower the intraocular pressure. The clinician must weigh the advantages of subconjunctival repository corticosteroid administration against the difficulty of withdrawal of the drug if undesirable side effects occur.